The UK is leading the rest of Europe for early-stage clinical research into new medicines and vaccines, with more than 600 commercial clinical trials taking place in the NHS.
We have launched our General Election manifesto calling on all parties to ensure that their policies support UK science and research and help maintain the UK’s position as a global leader in medicines and vaccines development into the future.
The Smith-Reid review into science and research funding post-Brexit has been published with recommendations for how the UK Government can promote an exciting, well-resourced vision for international collaboration in research and innovation.
NHS England has today published a draft commercial framework setting out more operational detail on commercial arrangements with industry. There will now be an engagement process to make sure that the final framework is informed by a broad range of views.
NHS England has announced it has secured an agreement with Vertex to make available all three of their UK-licensed cystic fibrosis medicines.
The Department of Health and Social Care has published the Q2 2019 Voluntary Scheme measured spend and payment data, showing that in first two quarters of this year the total branded sales growth was 0.6%.
The short answer is, no – but for those wanting a more complete explanation, read on...
The Department for Transport has today announced details of the freight capacity it has secured to prepare for a 'no-deal' Brexit.
In a speech today, Jeremy Corbyn highlighted concerns about the price of medicines, and reiterated Labour's proposals for compulsory licensing.
The National Audit Office (NAO) has publish a new report – Exiting the EU: supplying the health and social care sectors– into the progress made by the DHSC, working with others, to secure continuity of supply for health and social care sectors should the UK depart the EU without a deal on 31...